Package 0143-9098-01

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "e673dbf4-9d4e-4665-ac36-81c6537044fc", "openfda": {"nui": ["N0000175604", "N0000175075"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["854be921-5fd9-482a-8432-a0c0241625f8"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0143-9098-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "0143-9098-01", "marketing_start_date": "20220727"}], "brand_name": "bortezomib", "product_id": "0143-9098_e673dbf4-9d4e-4665-ac36-81c6537044fc", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "0143-9098", "generic_name": "bortezomib", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bortezomib", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "ANDA215011", "marketing_category": "ANDA", "marketing_start_date": "20220727", "listing_expiration_date": "20261231"}